ControlledRelease Capsules
Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham Heart Study
For instance, trastuzumab (a monoclonal antibody) is designed to target the HER2 receptor in the case of HER2-positive tumors, where it has demonstrated a significant improvement in survival rates (disease-free as well as overall survival) in early stage and metastatic disease settings (217)
Although GLP-1 agonists are chiefly used to treat chronic diseases like type 2 diabetes and obesity, theyve become popular as weight management drugs, too
Research shows that dose responsiveness varies significantly between individuals, with factors including metabolic adaptation, GLP-1 receptor polymorphisms, concurrent medication interactions, and adherence patterns all influencing clinical outcomes